TP53 and melanoma: More importantly, combining vemurafenib and PRIMA-1Met potentiates the RT effect in melanoma cells and induces the better inhibition of cell survival and a massive induction of cell death compared to the effect of irradiation and p53 reactivation or irradiation and BRAF inhibition (Figure 1D).